Pharmaceutically acceptable salt of a substituted benzofuranyl-ethyl-piperazinyl compound.

PK201100629A0Undetermined Publication Date: 2011-09-14MERCK SHARP & DOHME CORP
0 Cites 0 Cited by

Patent Information

Application Number
PK201100629
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Filing Date
2011-08-27
Publication Date
2011-09-14
Patent Text Reader

Abstract

This invention relates to a pharmaceutically acceptable salt of a compound having structural Formula I: which is an inhibitor of the Renal Outer Medullary Potassium (ROMK) channel (Kirl.l). The pharmaceutically acceptable salt of the compound of Formula I is useful as diuretic and natriuretic and therefore is useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure
Need to check novelty before this filing date? Find Prior Art